US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teva Pharmaceutical

16.93

-1.1400-6.31%

Post-market: 17.020.0900+0.53%19:57 EDT

Volume:19.07M

Turnover:330.18M

Market Cap:19.42B

PE:-14.82

High:18.25

Open:18.20

Low:16.89

Close:18.07

Loading ...

Overview Company News Filings

Update: Teva, Sanofi Shares Jump as Phase 2B Duvakitug Study Meets Primary Endpoints in Inflammatory Bowel Disease

MT Newswires Live

Teva Stock Soars 19% as Game-Changing IBD Drug Duvakitug Crushes Trial Expectations

Teva rises 19.2%

U.S.-Listing of Teva Pharmaceuticals up 15.6% After Co's Bowel Disease Drug With Sanofi Meets Main Goals in Mid-Stage Trial

THOMSON REUTERS

Teva Shares Soar on Early Bowel Disease Drug Data -- Barrons.com

Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?

Teva, Sanofi Say Phase 2B Duvakitug Study Meets Primary Endpoints in Inflammatory Bowel Disease

MT Newswires Live

Pre-Bell｜U.S. Futures Dip; Tesla Gains 2%; Nvidia Drops 2%; Palantir Sinks 3%; Quantum Stocks Shine

Tiger Newspress

Teva, Sanofi Say IBD Treatment Achieved Higher Remission at Trial

Teva, Sanofi Say Drug to Treat IBD Met Primary Targets

U.S.-Listing of Teva Pharmaceuticals up 21% Premarket After Co's Bowel Disease Drug With Sanofi Meets Main Goals in Mid-Stage Trial

THOMSON REUTERS

Teva announces new patient access program with Direct Relief

Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients

Teva Pharmaceutical's AJOVY® is Proven to be Effective in Children with Migraine

Teva Pharmaceutical to Divest Japanese Venture to JKI

MT Newswires Live

Teva to divest Teva-Takeda business venture in Japan

Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan

Teva presents data from SPACE study

Teva Pharmaceutical Says Migraine Prevention Drug Shows Efficacy in Younger Patients

MT Newswires Live

TEVA Stock Down 10% in a Month: Should You Buy the Dip?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TEVA/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TEVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TEVA\",,,,,undefined,":{"symbol":"TEVA","market":"US","secType":"STK","nameCN":"Teva Pharmaceutical","latestPrice":16.93,"timestamp":1746820800000,"preClose":18.07,"halted":0,"volume":19074501,"hourTrading":{"tag":"盘后","latestPrice":17.02,"preClose":16.93,"latestTime":"19:57 EDT","volume":611037,"amount":10346958.7732,"timestamp":1746835021577},"delay":0,"floatShares":1141911052,"shares":1146959855,"eps":-1.142604,"marketStatus":"Market Closed","change":-1.14,"latestTime":"05-09 16:00:00 EDT","open":18.2,"high":18.25,"low":16.89,"amount":330176980.028862,"amplitude":0.075263,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.142604,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"adr":0,"adrRate":1,"exchange":"NYSE","adjPreClose":18.07,"dividendRate":0.000059,"preHourTrading":{"tag":"盘前","latestPrice":18.18,"preClose":18.07,"latestTime":"09:29 EDT","volume":17892,"amount":324840.8898,"timestamp":1746797399080},"postHourTrading":{"tag":"盘后","latestPrice":17.02,"preClose":16.93,"latestTime":"19:57 EDT","volume":611037,"amount":10346958.7732,"timestamp":1746835021577},"volumeRatio":0.9808320855519403,"impliedVol":0.5154,"impliedVolPercentile":0.584},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TEVA\",,,,,undefined,":{"symbol":"TEVA","floatShares":1141911052,"roa":"5.27%","roe":"-19.11%","lyrEps":-1.44916,"volumeRatio":0.9808320855519403,"shares":1146959855,"dividePrice":0.001,"high":18.25,"amplitude":0.075263,"preClose":18.07,"low":16.89,"week52Low":12.465,"pbRate":"3.10","psRate":"1.17","week52High":22.8,"institutionHeld":0.5897,"latestPrice":16.93,"eps":-1.142604,"divideRate":0.000059,"volume":19074501,"delay":0,"ttmEps":-1.142604,"open":18.2,"prevYearClose":22.04,"prevWeekClose":16.19,"prevMonthClose":15.51,"prevQuarterClose":15.37,"fiveDayClose":16.19,"twentyDayClose":12.82,"sixtyDayClose":16.34},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TEVA\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2492998051","title":"Update: Teva, Sanofi Shares Jump as Phase 2B Duvakitug Study Meets Primary Endpoints in Inflammatory Bowel Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2492998051","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492998051?lang=en_us&edition=fundamental","pubTime":"2024-12-18 01:24","pubTimestamp":1734456257,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries'  US-listed shares jumped 23% in recent Tuesday trading after the company's co-developed drug duvakitug was found to benefit patients with inflammatory bowel disease.Teva's US affiliate Teva Pharmaceuticals and Sanofi  said that a phase 2b study on duvakitug met primary endpoints in patients with ulcerative colitis and Crohn's disease, the most common forms of inflammatory bowel disease.Sanofi's US-listed shares jumped 6.4% after the news.The companies said 47.8% of ulcerative colitis patients treated with high-dose duvakitug achieved clinical remission at week 14 and 47.8% of Crohn's disease patients on high-dose duvakitug achieved endoscopic response.Duvakitug was well tolerated, with adverse event rates similar between treatment and placebo groups, the companies added.Teva and Sanofi said they plan to initiate a phase 3 trial after regulatory discussions. Detailed results of the phase 2b trial are expected to be presented in 2025, they added.Price: 20.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4585","BK4584","SNY","SNYNF","TEVA","BK4557","BK4566","BK4559","BK4596","IE00BFXG1179.USD","BK4588"],"gpt_icon":0},{"id":"2492998324","title":"Teva Stock Soars 19% as Game-Changing IBD Drug Duvakitug Crushes Trial Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2492998324","media":"GuruFocus.com","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492998324?lang=en_us&edition=fundamental","pubTime":"2024-12-18 01:00","pubTimestamp":1734454811,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical  Industries and Sanofi  just dropped a game-changing update for investorstheir star drug duvakitug smashed expectations in Phase 2b trials, delivering clinical remission in nearly half of Crohn's disease patients at high doses. Conducted across the U.S., Europe, and Israel, the trial met its primary endpoints, showing 47.8% remission rates compared to 20.45% on placebo. The market loved it. Teva's stock skyrocketed 19%, while Sanofi saw a tidy 4% bump, and for good reasonthis positions duvakitug to claim a big slice of the $28 billion inflammatory bowel disease  market.GuruFocus has detected 2 Warning Signs with TEVA.Duvakitug isn't just another drug in Teva's pipelineit's the drug. With consistent efficacy across patient groups and no major safety hiccups, this TL1A antibody therapy is now a frontrunner in the fight against ulcerative colitis and Crohn's. Teva's R&D chief, Eric Hughes, didn't hold back, calling the results beyond expectations, while Sanofi's head o","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9QVg.4cfA8zfWdjG0PUEqQ--~B/aD00MjE7dz00MjE7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/eb52526e6c6491907a7e1ebdc6d8f21b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9QVg.4cfA8zfWdjG0PUEqQ--~B/aD00MjE7dz00MjE7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/eb52526e6c6491907a7e1ebdc6d8f21b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teva-stock-soars-19-game-170011719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BFTCPJ56.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","TEVA","LU0985320562.USD","LU2461242641.AUD","LU1585245621.USD","IBD","LU0265550946.USD","LU0234572021.USD","LU0965508806.USD","LU1066051498.USD","LU1989772840.SGD","SG9999001440.SGD","LU1983299246.USD","BK4588","LU0203345920.USD","IE00BLSP4239.USD","LU0122379950.USD","BK4557","LU1699723380.USD","LU1093756168.USD","BK4534","MRK","LU0238689110.USD","LU0211331839.USD","LU1037948897.HKD","LU0006306889.USD","SG9999015358.SGD","LU2468319806.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU0266013472.USD","LU1116320737.USD","LU0265550359.USD","IE00BBT3K403.USD","LU1934455863.HKD","BK4566","BK4516","BK4007","LU1037948541.HKD","LU1941712264.USD","LU1974910355.USD","SNY","LU0058720904.USD","SG9999014559.SGD","LU2361045086.USD","IE0009355771.USD","LU2361044865.SGD","LU0965509010.AUD"],"gpt_icon":0},{"id":"2492996956","title":"Teva rises 19.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492996956","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492996956?lang=en_us&edition=fundamental","pubTime":"2024-12-17 23:00","pubTimestamp":1734447629,"startTime":"0","endTime":"0","summary":"Teva (TEVA) is up 19.2%, or $3.17 to $19.68. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-rises-19-2-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-rises-19-2-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","BK4585","BK4566","BK4559","BK4584","BK4588","BK4596","TEVA","BK4007"],"gpt_icon":0},{"id":"2492639299","title":"U.S.-Listing of Teva Pharmaceuticals up 15.6% After Co's Bowel Disease Drug With Sanofi Meets Main Goals in Mid-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2492639299","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492639299?lang=en_us&edition=fundamental","pubTime":"2024-12-17 22:36","pubTimestamp":1734446174,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nL4N3NI10V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4557","BK4588","BK4007","BK4566","BK4559","BK4596","BK4585","BK4584","TEVA"],"gpt_icon":0},{"id":"2492968641","title":"Teva Shares Soar on Early Bowel Disease Drug Data -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2492968641","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492968641?lang=en_us&edition=fundamental","pubTime":"2024-12-17 22:17","pubTimestamp":1734445020,"startTime":"0","endTime":"0","summary":"Shares of drugmaker Teva Pharmaceutical Industries were up more than 20% in premarket trading Tuesday on the back of promising early data on a treatment for two chronic bowel conditions.Teva and its partner Sanofi said that 47.8% of patients with ulcerative colitis who received a high dose of their drug duvakitug experienced clinical remission, compared with 20.5% who received a placebo.The results were similar for patients with Crohn's disease. The companies said that both responses were significant and clinically meaningful.Teva's American depositary receipts were up 20% in premarket trading, while ADRs of Sanofi, the far larger of the two partners, were up 4.1%.Crohn's disease and ulcerative colitis are both chronic inflammatory conditions impacting the colon. While there are a number of medicines on the market to treat the diseases, Teva called duvakitug \"potentially best-in-class\" in a presentation on Tuesday morning.\"These positive results reinforce Teva's ability to develop and ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEVA","BK4566","SNY","BK4007","BK4596","BK4588","BK4585","BK4584","BK4559","BK4557","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2492963561","title":"Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2492963561","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492963561?lang=en_us&edition=fundamental","pubTime":"2024-12-17 22:16","pubTimestamp":1734444992,"startTime":"0","endTime":"0","summary":"On Tuesday, Teva Pharmaceutical Industries Ltd.  and Sanofi SA’s  Phase 2b RELIEVE UCCD study met its primary endpoints in patients with ulcerative colitis  and Crohn’s disease .RELIEVE UCCD investigated duvakitug , a human IgG1-λ2 monoclonal antibody targeting TL1A, for moderate-to-severe inflammatory bowel disease .In the RELIEVE UCCD study, 36.2%  and 47.8%  of patients with ulcerative colitis treated with duvakitug achieved clinical remission compared to 20.45% on placebo, placebo-adjusted rates were 15.7%  and 27.4% , at week 14.Also Read: Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug. Overall, the treatment effect was consistent across subgroups.Duvakitug was generally well tolerated in ulcerative colitis and Crohn’s disease, with no safety signal identified.Ulcerative colitis and Crohn’s disease, the two main types of IBD, are chronic inflammatory conditions of the GI tract resulting in symptoms such as abd","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/KjRbkKbKpeJEOpjN7kNeqA--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/bb5745124c89d78e3ebe1a750f38aa02","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/KjRbkKbKpeJEOpjN7kNeqA--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/bb5745124c89d78e3ebe1a750f38aa02"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-teva-sanofi-stocks-trading-141632272.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4557","SNYNF","SNY","BK4588","AE","BK4596","BK4116","CD","BK4007","TEVA","IBD","BK4585","BK4584","BK4566","IE00BFXG1179.USD","BK4559","BK4138"],"gpt_icon":0},{"id":"2492957101","title":"Teva, Sanofi Say Phase 2B Duvakitug Study Meets Primary Endpoints in Inflammatory Bowel Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2492957101","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492957101?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:43","pubTimestamp":1734442998,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries'  US affiliate Teva Pharmaceuticals and Sanofi  said Tuesday that a phase 2b study on duvakitug met primary endpoints in patients with ulcerative colitis and Crohn's disease, the most common forms of inflammatory bowel disease.The companies said 47.8% of ulcerative colitis patients treated with high-dose duvakitug achieved clinical remission at week 14 and 47.8% of Crohn's disease patients on high-dose duvakitug achieved endoscopic response.Duvakitug was well tolerated, with adverse event rates similar between treatment and placebo groups, the companies added.Teva and Sanofi said they plan to initiate a phase 3 trial after regulatory discussions. Detailed results of the phase 2b trial are expected to be presented in 2025, they added.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4584","BK4559","BK4588","IE00BFXG1179.USD","BK4585","SNYNF","TEVA","SNY","BK4557","BK4566","BK4596","BK4007"],"gpt_icon":0},{"id":"1163081867","title":"Pre-Bell｜U.S. Futures Dip; Tesla Gains 2%; Nvidia Drops 2%; Palantir Sinks 3%; Quantum Stocks Shine","url":"https://stock-news.laohu8.com/highlight/detail?id=1163081867","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163081867?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:43","pubTimestamp":1734442980,"startTime":"0","endTime":"0","summary":"U.S. stock index futures dipped on Tuesday, with rising bond yields adding pressure as traders braced for retail sales data that will provide more clues on the health of consumers ahead of an anticipa","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3b1e74be79ddbb8b0eefa5ab5c7ba16b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDA","AFRM","QUBT","EVGO","TEVA","QBTS","PLTR","AMTM","PFE","ESmain",".DJI","QMCO",".IXIC","AVGO","NET","TSLA","NUE",".SPX","YMmain","SEDG","SNY","RCAT","RGTI","NQmain"],"gpt_icon":1},{"id":"2492195222","title":"Teva, Sanofi Say IBD Treatment Achieved Higher Remission at Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2492195222","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492195222?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:30","pubTimestamp":1734442200,"startTime":"0","endTime":"0","summary":"Teva Pharmaceuticals and Sanofi report that the latest trial of their jointly developed treatment for inflammatory bowel disease met its primary endpoints.The companies said Tuesday that patients with ulcerative colitis who were treated with duvakitug achieved a higher rate of clinical remission compared with a placebo group. A group of patients with Crohn's disease who were treated with duvakitug achieved a higher rate of remission than those treated with a placebo.The treatment effect was consistent across subgroups, the companies said.Teva's shares surged 18% to $19.53 in premarket trading. Sanofi's American depositary receipts were up 3.7% at $47.57.Duvakitug was generally well tolerated across both patient groups and showed similar rates of treatment-emergent adverse events.\"I am deeply moved by the potential for duvakitug to help treat and meaningfully improve the quality of life of people living with IBD,\" Hughes said.Teva and Sanofi said in November 2023 that they had closed a ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","TEVA","BK4559","BK4596","BK4585","IBD","BK4007","BK4588","IE00BFXG1179.USD","SNY","SNYNF","BK4557","BK4584"],"gpt_icon":0},{"id":"2492959530","title":"Teva, Sanofi Say Drug to Treat IBD Met Primary Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=2492959530","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492959530?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:10","pubTimestamp":1734441000,"startTime":"0","endTime":"0","summary":"Teva, Sanofi say drug to treat IBD met primary targetsBy Steven Scheer","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nL8N3NI0PE:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Teva, Sanofi Say Drug to Treat IBD Met Primary Targets","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY","TEVA"],"gpt_icon":1},{"id":"2492954365","title":"U.S.-Listing of Teva Pharmaceuticals up 21% Premarket After Co's Bowel Disease Drug With Sanofi Meets Main Goals in Mid-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2492954365","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492954365?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:00","pubTimestamp":1734440421,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nL4N3NI0WI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4566","BK4007","BK4584","BK4588","BK4559","BK4596","TEVA","BK4557"],"gpt_icon":0},{"id":"2490585455","title":"Teva announces new patient access program with Direct Relief","url":"https://stock-news.laohu8.com/highlight/detail?id=2490585455","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490585455?lang=en_us&edition=fundamental","pubTime":"2024-12-11 21:10","pubTimestamp":1733922643,"startTime":"0","endTime":"0","summary":"Teva (TEVA) Pharmaceuticals announced the launch of a new patient access program, in partnership with Direct Relief, to supply inhalers to eligible...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-announces-new-patient-access-program-with-direct-relief?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-announces-new-patient-access-program-with-direct-relief?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","BK4007","TEVA","BK4557","BK4559","BK4584","BK4585","BK4596","BK4588"],"gpt_icon":0},{"id":"2490852333","title":"Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2490852333","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490852333?lang=en_us&edition=fundamental","pubTime":"2024-12-11 21:00","pubTimestamp":1733922000,"startTime":"0","endTime":"0","summary":"Teva to provide two generic inhaler products to Direct Relief for its network of free and charitable clinics. The program, launching this month, will run for a minimum of three years. PARSIPPANY, N.J., Dec. 11, 2024  -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , announced today the launch of a new patient access program, in partnership with Direct Relief, to supply inhalers to eligible patients in the United States free of charge.Teva Pharmaceutical Industries Ltd.  is a global pharmaceutical leader with a category-defying portfolio, harnessing our generics expertise and stepping up innovation to continue the momentum behind the discovery, delivery, and expanded development of modern medicine. For over 120 years, Teva's commitment to bettering health has never wavered. Today, the","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/XwFOISkRqN7CQhHtR27STw--~B/aD03NzY7dz0yMTYxO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/3b415d420da1c3b6c2f46c0b50343a66","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/XwFOISkRqN7CQhHtR27STw--~B/aD03NzY7dz0yMTYxO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/3b415d420da1c3b6c2f46c0b50343a66"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teva-announces-patient-access-program-130000841.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TEVA"],"gpt_icon":0},{"id":"2489744230","title":"Teva Pharmaceutical's AJOVY® is Proven to be Effective in Children with Migraine","url":"https://stock-news.laohu8.com/highlight/detail?id=2489744230","media":"GuruFocus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489744230?lang=en_us&edition=fundamental","pubTime":"2024-12-06 22:20","pubTimestamp":1733494855,"startTime":"0","endTime":"0","summary":"AJOVY  was first aimed to prevent episodic migraine in adults and Teva Pharmaceutical  wonders if the same drug gives effective results to children with migraine.And Teva just recently announced positive results from its Phase 3 SPACE  evaluating AJOVY for the prevention of episodic migraine in children and adolescents aged 6-17 years. The trial demonstrated statistically significant superior efficacy compared to placebo over 12 weeks, with a favorable safety profile consistent with that observed in adults.The study included 237 children who had been diagnosed with migraine for at least six months, with fewer than 14 headache days per month. Highlights from the data showed that fremanezumab achieved a significant reduction in monthly migraine days and monthly headache days compared to placebo2. Additionally, a higher number of children achieved a 50% response rate with fremanezumab compared to placebo.This brings hopes to treat young patients who live with migraine, a condition with li","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2625887/teva-pharmaceuticals-ajovy-is-proven-to-be-effective-in-children-with-migraine","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["TEVA"],"gpt_icon":0},{"id":"2489408115","title":"Teva Pharmaceutical to Divest Japanese Venture to JKI","url":"https://stock-news.laohu8.com/highlight/detail?id=2489408115","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489408115?lang=en_us&edition=fundamental","pubTime":"2024-12-06 16:31","pubTimestamp":1733473892,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries  said late Thursday it has agreed to divest all shares of Teva Takeda Pharma and its Teva Takeda Yakuhin subsidiary to JKI, which was established by the fund managed and operated by J-Will Partners.Financial terms were not disclosed.All the employees of the transferred business venture will remain employed, the company said.Teva said the divestment, expected to be completed by April 1, will allow it to focus on its medicines business in Japan.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","TEVA","BK4584","BK4007","BK4566","BK4557","JKI","BK4559","BK4585","BK4596"],"gpt_icon":0},{"id":"2489744859","title":"Teva to divest Teva-Takeda business venture in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2489744859","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489744859?lang=en_us&edition=fundamental","pubTime":"2024-12-06 07:05","pubTimestamp":1733439917,"startTime":"0","endTime":"0","summary":"Teva (TEVA) Pharmaceutical has entered into an agreement with JKI, established by the fund managed and operated by J-Will, whereby all shares of Te...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-to-divest-teva-takeda-business-venture-in-japan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-to-divest-teva-takeda-business-venture-in-japan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","BK4585","BK4566","BK4559","BK4584","BK4588","BK4596","TEVA","BK4007"],"gpt_icon":0},{"id":"2489495654","title":"Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2489495654","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489495654?lang=en_us&edition=fundamental","pubTime":"2024-12-06 07:00","pubTimestamp":1733439600,"startTime":"0","endTime":"0","summary":"Teva entered into an agreement with JKI Co., Ltd.  established by the fund managed and operated by private equity firm J-Will Partners Co., Ltd. , through which JKI will acquireTeva-Takeda. The agreement is aligned with Teva's Pivot to Growth strategy to focus its business. The expected divestment of Teva-Takeda, Teva's business venture in Japan, which includes generics products and legacy products, will allow Teva to focus on bringing its innovative medicines to the Japanese market. Teva recently communicated that it was open to exploring new strategic approaches in Japan, including a possible divestment of its Teva-Takeda business venture, in alignment with its Pivot to Growth strategy. The divestment will allow Teva to focus on its innovative medicines business in Japan.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/XwFOISkRqN7CQhHtR27STw--~B/aD03NzY7dz0yMTYxO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/3b415d420da1c3b6c2f46c0b50343a66","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/XwFOISkRqN7CQhHtR27STw--~B/aD03NzY7dz0yMTYxO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/3b415d420da1c3b6c2f46c0b50343a66"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teva-announces-agreement-divest-teva-230000143.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TEVA"],"gpt_icon":0},{"id":"2488166616","title":"Teva presents data from SPACE study","url":"https://stock-news.laohu8.com/highlight/detail?id=2488166616","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488166616?lang=en_us&edition=fundamental","pubTime":"2024-12-04 18:40","pubTimestamp":1733308814,"startTime":"0","endTime":"0","summary":"Teva (TEVA) presented data from its Phase 3 SPACE study evaluating the efficacy and safety of Ajovy for the prevention of episodic migraine in chil...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-presents-data-from-space-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-presents-data-from-space-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4559","TEVA","BK4557","BK4596","BK4588","BK4584","BK4566","BK4007","BK4585"],"gpt_icon":0},{"id":"2488527691","title":"Teva Pharmaceutical Says Migraine Prevention Drug Shows Efficacy in Younger Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2488527691","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488527691?lang=en_us&edition=fundamental","pubTime":"2024-12-04 17:25","pubTimestamp":1733304303,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries  said Wednesday a phase 3 study of its fremanezumab drug to prevent episodic migraine in patients aged 6 to 17 years showed \"statistically significant superior efficacy\" compared with placebo.The drug also showed a favorable safety profile \"consistent with that observed in the adult population,\" the company said.Teva said it continues to study the impact of fremanezumab on pediatric patients with chronic migraines and its long-term safety.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4557","BK4584","BK4559","BK4566","TEVA","BK4585","BK4588","BK4596"],"gpt_icon":0},{"id":"2487326674","title":"TEVA Stock Down 10% in a Month: Should You Buy the Dip?","url":"https://stock-news.laohu8.com/highlight/detail?id=2487326674","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487326674?lang=en_us&edition=fundamental","pubTime":"2024-11-29 04:00","pubTimestamp":1732824000,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries Limited’s TEVA stock has declined 10% in a month despite strong third-quarter results announced earlier this month. The company beat estimates for earnings as well as sales. The company also slightly raised its earnings and sales guidance. The stock probably declined as investors were not impressed with the guidance increase. However, some analysts believe the stock’s decline after the results was an overreaction.Teva is the world’s largest generic drug company in terms of both total and new prescriptions. The company also markets some branded drugs. Let's discuss the company’s strengths and weaknesses in detail to understand whether the stock’s recent price decline should be used as a buying opportunity for long-term investors.The company is seeing continued market share growth of its two newest drugs, Austedo and Ajovy. Though Teva is seeing slower growth of Ajovy in the U.S. market, it expects sales to benefit from continued patient growth and launches","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/.vcXZvNbnFvDkPdENtrKng--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f84faa3d65021260b4cd14c75493ef6c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/.vcXZvNbnFvDkPdENtrKng--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f84faa3d65021260b4cd14c75493ef6c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teva-stock-down-10-month-200000525.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4534","LU0234570918.USD","LU0553294199.USD","LU1674673691.USD","SNY","LU2237443622.USD","LU0114720955.EUR","BK4139","IE00BSNM7G36.USD","LU0289739699.SGD","LU1718418525.SGD","LU0949170772.SGD","BK4584","LU1839511570.USD","LU1267930573.SGD","LU1280957306.USD","LU0820561909.HKD","LU1496350502.SGD","BK4581","IE00B19Z3B42.SGD","BK4588","IE00B19Z3581.USD","LU0058720904.USD","LU1244550577.SGD","LU0198837287.USD","LU1267930490.SGD","LU0965508806.USD","LU1674673428.USD","SG9999003800.SGD","LU0122379950.USD","IE00B4R5TH58.HKD","SG9999011175.SGD","ABBV","LU0170899867.USD","IE00B42XCP33.USD","IE00BVYPNV92.GBP","LU1066051498.USD","LU0456855351.SGD","LU0820561818.USD","LU1066053197.SGD","LU1244550494.USD","JNJ","LU1061106388.HKD","FTF","LU1267930813.SGD","LU0912757837.SGD","LU0965509283.SGD","LU1732799900.SGD","TEVA"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TEVA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"TEVA","fiscalQuarterEnding":"2025/03","expectedEps":0.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"pre","actualEps":0.49},{"market":"US","date":"2025-01-29","symbol":"TEVA","fiscalQuarterEnding":"2024/12","expectedEps":0.66,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738126800000,"reportTimeType":"pre","actualEps":0.7},{"market":"US","date":"2024-11-06","symbol":"TEVA","fiscalQuarterEnding":"2024/09","expectedEps":0.63,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"pre","actualEps":0.67},{"market":"US","date":"2024-07-31","symbol":"TEVA","fiscalQuarterEnding":"2024/06","expectedEps":0.55,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722398400000,"reportTimeType":"pre","actualEps":0.58},{"market":"US","date":"2024-05-08","symbol":"TEVA","fiscalQuarterEnding":"2024/03","expectedEps":0.49,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":0.46}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TEVA\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-15","recordDate":"2015-05-19","paymentDate":"2015-06-04","value":0.289,"currency":"USD"},{"executeDate":"2015-08-18","recordDate":"2015-08-20","paymentDate":"2015-09-03","value":0.289,"currency":"USD"},{"executeDate":"2015-11-13","recordDate":"2015-11-17","paymentDate":"2015-12-03","value":0.289,"currency":"USD"},{"executeDate":"2016-02-25","recordDate":"2016-02-29","paymentDate":"2016-03-14","value":0.289,"currency":"USD"},{"executeDate":"2016-05-20","recordDate":"2016-05-24","paymentDate":"2016-06-07","value":0.289,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TEVA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.4,"hold":0.2,"sell":0.1,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4,"analysts":10,"updateTime":1744430400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TEVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TEVA","date":"2025-05-09","current":-16.116302,"percent":0.219133,"low":-47.420609,"twenty":-16.84738,"median":-5.284921,"eighty":-2.637593,"high":3468.133499,"avg":130.693252,"sd":595.659059,"marketCap":20725564579},"quantilePoints":[{"date":"2020-05-15","current":-14.885858,"twenty":-2.613582,"median":9.349002,"eighty":19.522154,"marketCap":12280832750},{"date":"2020-05-22","current":-15.881789,"twenty":-2.632889,"median":9.056128,"eighty":19.463066,"marketCap":13102476332},{"date":"2020-05-29","current":-16.638698,"twenty":-2.654284,"median":8.493918,"eighty":19.399513,"marketCap":13726925455},{"date":"2020-06-05","current":-17.050349,"twenty":-2.677451,"median":8.27121,"eighty":19.316592,"marketCap":14066538136},{"date":"2020-06-12","current":-14.938974,"twenty":-2.691669,"median":7.55798,"eighty":19.246698,"marketCap":12324653741},{"date":"2020-06-19","current":-16.824605,"twenty":-2.723388,"median":6.839112,"eighty":19.224557,"marketCap":13880298924},{"date":"2020-06-26","current":-16.187209,"twenty":-2.746903,"median":6.605128,"eighty":19.137656,"marketCap":13354447031},{"date":"2020-07-02","current":-15.071765,"twenty":-2.770437,"median":-1.045636,"eighty":19.099162,"marketCap":12434206218},{"date":"2020-07-10","current":-15.616208,"twenty":-2.790652,"median":-1.062517,"eighty":19.081439,"marketCap":12883371377},{"date":"2020-07-17","current":-16.412953,"twenty":-2.805417,"median":-1.079484,"eighty":19.030594,"marketCap":13540686243},{"date":"2020-07-24","current":-15.257672,"twenty":-2.827292,"median":-1.105759,"eighty":18.98189,"marketCap":12587579687},{"date":"2020-07-31","current":-15.324068,"twenty":-2.849167,"median":-1.116081,"eighty":18.936119,"marketCap":12642355926},{"date":"2020-08-07","current":3268.239835,"twenty":-2.855117,"median":-1.118783,"eighty":18.907339,"marketCap":13072959341},{"date":"2020-08-14","current":3150.35627,"twenty":-2.855117,"median":-1.118783,"eighty":18.907339,"marketCap":12601425081},{"date":"2020-08-21","current":2709.306392,"twenty":-2.855117,"median":-1.118783,"eighty":18.907339,"marketCap":10837225569},{"date":"2020-08-28","current":2629.862625,"twenty":-2.855117,"median":-1.118783,"eighty":18.907339,"marketCap":10519450502},{"date":"2020-09-04","current":2517.545576,"twenty":-2.855117,"median":-1.118783,"eighty":18.907339,"marketCap":10070182303},{"date":"2020-09-11","current":2407.967966,"twenty":-2.855117,"median":-1.118783,"eighty":18.907339,"marketCap":9631871866},{"date":"2020-09-18","current":2596.989343,"twenty":-2.855117,"median":-1.118783,"eighty":18.907339,"marketCap":10387957371},{"date":"2020-09-25","current":2388.791885,"twenty":-2.855117,"median":-1.118783,"eighty":18.907339,"marketCap":9555167539},{"date":"2020-10-02","current":2470.975092,"twenty":-2.855117,"median":-1.118783,"eighty":18.94668,"marketCap":9883900367},{"date":"2020-10-09","current":2692.869751,"twenty":-2.855117,"median":-1.118783,"eighty":18.94668,"marketCap":10771479004},{"date":"2020-10-16","current":2577.813261,"twenty":-2.855117,"median":-1.118783,"eighty":18.94668,"marketCap":10311253044},{"date":"2020-10-23","current":2561.376619,"twenty":-2.855117,"median":-1.118783,"eighty":18.960483,"marketCap":10245506478},{"date":"2020-10-30","current":2388.791885,"twenty":-2.855117,"median":-1.118783,"eighty":18.970629,"marketCap":9555167539},{"date":"2020-11-06","current":-2.479598,"twenty":-2.855117,"median":-1.122535,"eighty":18.977532,"marketCap":9995260590},{"date":"2020-11-13","current":-2.580196,"twenty":-2.855117,"median":-1.13285,"eighty":18.977532,"marketCap":10400770066},{"date":"2020-11-20","current":-2.577477,"twenty":-2.855117,"median":-1.159421,"eighty":18.970629,"marketCap":10389810350},{"date":"2020-11-27","current":-2.669918,"twenty":-2.855117,"median":-1.167378,"eighty":18.907339,"marketCap":10762440679},{"date":"2020-12-04","current":-2.794986,"twenty":-2.855117,"median":-1.19662,"eighty":18.876363,"marketCap":11266587595},{"date":"2020-12-11","current":-2.80858,"twenty":-2.868879,"median":-1.206311,"eighty":18.831741,"marketCap":11321386173},{"date":"2020-12-18","current":-2.721577,"twenty":-2.868879,"median":-1.218948,"eighty":18.767819,"marketCap":10970675275},{"date":"2020-12-24","current":-2.672637,"twenty":-2.868879,"median":-1.245853,"eighty":18.713856,"marketCap":10773400395},{"date":"2020-12-31","current":-2.623698,"twenty":-2.868879,"median":-1.254451,"eighty":18.705041,"marketCap":10576125515},{"date":"2021-01-08","current":-2.933648,"twenty":-2.890141,"median":-1.330328,"eighty":18.653693,"marketCap":11825533089},{"date":"2021-01-15","current":-3.251754,"twenty":-2.93694,"median":-1.36644,"eighty":18.618565,"marketCap":13107819809},{"date":"2021-01-22","current":-3.412166,"twenty":-2.970208,"median":-1.391911,"eighty":18.571548,"marketCap":13754443027},{"date":"2021-01-29","current":-3.202814,"twenty":-3.004914,"median":-1.411761,"eighty":18.521647,"marketCap":12910544929},{"date":"2021-02-05","current":-3.327882,"twenty":-3.040774,"median":-1.489022,"eighty":18.485499,"marketCap":13414691845},{"date":"2021-02-12","current":-3.055943,"twenty":-3.075085,"median":-1.495472,"eighty":18.465291,"marketCap":12193211794},{"date":"2021-02-19","current":-3.033958,"twenty":-3.084796,"median":-1.519016,"eighty":18.419652,"marketCap":12105490846},{"date":"2021-02-26","current":-2.957009,"twenty":-3.090354,"median":-1.528691,"eighty":18.381903,"marketCap":11798467527},{"date":"2021-03-05","current":-2.891054,"twenty":-3.092207,"median":-1.533851,"eighty":18.348285,"marketCap":11535304683},{"date":"2021-03-12","current":-2.965254,"twenty":-3.094346,"median":-1.548687,"eighty":18.29633,"marketCap":11831362883},{"date":"2021-03-19","current":-3.165869,"twenty":-3.107046,"median":-1.557072,"eighty":18.276086,"marketCap":12631816535},{"date":"2021-03-26","current":-3.182358,"twenty":-3.123547,"median":-1.569004,"eighty":18.273427,"marketCap":12697607246},{"date":"2021-04-01","current":-3.154876,"twenty":-3.132058,"median":-1.587972,"eighty":18.270767,"marketCap":12587956060},{"date":"2021-04-09","current":-3.033958,"twenty":-3.14019,"median":-1.643277,"eighty":18.240014,"marketCap":12105490846},{"date":"2021-04-16","current":-2.954261,"twenty":-3.14019,"median":-1.74145,"eighty":18.209845,"marketCap":11787502409},{"date":"2021-04-23","current":-2.829086,"twenty":-3.14019,"median":-1.782486,"eighty":18.152512,"marketCap":11288054497},{"date":"2021-04-30","current":-2.962113,"twenty":-3.140098,"median":-1.805963,"eighty":18.125512,"marketCap":11795135070},{"date":"2021-05-07","current":-2.864508,"twenty":-3.140098,"median":-1.838334,"eighty":18.125512,"marketCap":11406472230},{"date":"2021-05-14","current":-2.911332,"twenty":-3.140098,"median":-1.872266,"eighty":18.125512,"marketCap":11592924180},{"date":"2021-05-21","current":-3.035277,"twenty":-3.140098,"median":-1.892281,"eighty":18.125512,"marketCap":12086473459},{"date":"2021-05-28","current":-2.864508,"twenty":-3.140098,"median":-1.900028,"eighty":18.125512,"marketCap":11406472230},{"date":"2021-06-04","current":-2.864508,"twenty":-3.140098,"median":-1.934046,"eighty":18.123394,"marketCap":11406472230},{"date":"2021-06-11","current":-3.060066,"twenty":-3.140793,"median":-1.942725,"eighty":18.095231,"marketCap":12185183315},{"date":"2021-06-18","current":-2.787387,"twenty":-3.140793,"median":-1.955715,"eighty":18.095231,"marketCap":11099374901},{"date":"2021-06-25","current":-2.853491,"twenty":-3.140793,"median":-1.962405,"eighty":18.095231,"marketCap":11362601183},{"date":"2021-07-02","current":-2.707511,"twenty":-3.140793,"median":-1.971497,"eighty":18.095231,"marketCap":10781309810},{"date":"2021-07-09","current":-2.561532,"twenty":-3.140793,"median":-1.979274,"eighty":18.095231,"marketCap":10200018436},{"date":"2021-07-16","current":-2.371482,"twenty":-3.140793,"median":-1.99345,"eighty":18.065112,"marketCap":9443242875},{"date":"2021-07-23","current":-2.426569,"twenty":-3.140793,"median":-2.00987,"eighty":18.020915,"marketCap":9662598110},{"date":"2021-07-30","current":-2.718479,"twenty":-3.140793,"median":-2.02672,"eighty":17.936008,"marketCap":10642846609},{"date":"2021-08-06","current":-2.819894,"twenty":-3.140793,"median":-2.047324,"eighty":17.86933,"marketCap":11039885446},{"date":"2021-08-13","current":-2.769187,"twenty":-3.140793,"median":-2.064068,"eighty":17.7757,"marketCap":10841366027},{"date":"2021-08-20","current":-2.574808,"twenty":-3.140793,"median":-2.081189,"eighty":17.662044,"marketCap":10080374923},{"date":"2021-08-27","current":-2.633967,"twenty":-3.140793,"median":-2.096758,"eighty":17.589353,"marketCap":10311980911},{"date":"2021-09-03","current":-2.670589,"twenty":-3.140793,"median":-2.136235,"eighty":17.521986,"marketCap":10455356047},{"date":"2021-09-10","current":-2.588894,"twenty":-3.140793,"median":-2.157064,"eighty":17.392,"marketCap":10135519206},{"date":"2021-09-17","current":-2.532552,"twenty":-3.140793,"median":-2.16522,"eighty":17.258426,"marketCap":9914942074},{"date":"2021-09-24","current":-2.521284,"twenty":-3.140793,"median":-2.180608,"eighty":17.140589,"marketCap":9870826648},{"date":"2021-10-01","current":-2.732565,"twenty":-3.140793,"median":-2.190178,"eighty":16.863606,"marketCap":10697990892},{"date":"2021-10-08","current":-2.86215,"twenty":-3.140623,"median":-2.212175,"eighty":16.581714,"marketCap":11205318295},{"date":"2021-10-15","current":-2.726931,"twenty":-3.140623,"median":-2.224813,"eighty":16.430857,"marketCap":10675933179},{"date":"2021-10-22","current":-2.853699,"twenty":-3.140623,"median":-2.234816,"eighty":16.203499,"marketCap":11172231725},{"date":"2021-10-29","current":13.278626,"twenty":-3.140623,"median":-2.237038,"eighty":15.915254,"marketCap":9640282648},{"date":"2021-11-05","current":13.871151,"twenty":-3.140623,"median":-2.237038,"eighty":14.703723,"marketCap":10070455443},{"date":"2021-11-12","current":14.448482,"twenty":-3.140623,"median":-2.237038,"eighty":14.141585,"marketCap":10489598167},{"date":"2021-11-19","current":13.491327,"twenty":-3.140623,"median":-2.237038,"eighty":14.007714,"marketCap":9794703651},{"date":"2021-11-26","current":12.898803,"twenty":-3.140623,"median":-2.237038,"eighty":13.603755,"marketCap":9364530856},{"date":"2021-12-03","current":12.230314,"twenty":-3.140623,"median":-2.237038,"eighty":13.26951,"marketCap":8879207702},{"date":"2021-12-10","current":12.670909,"twenty":-3.140623,"median":-2.237038,"eighty":12.871456,"marketCap":9199079781},{"date":"2021-12-17","current":12.458208,"twenty":-3.140623,"median":-2.237038,"eighty":12.652866,"marketCap":9044658777},{"date":"2021-12-23","current":12.853224,"twenty":-3.140623,"median":-2.237038,"eighty":12.613301,"marketCap":9331440641},{"date":"2021-12-31","current":12.169542,"twenty":-3.140623,"median":-2.237038,"eighty":12.5674,"marketCap":8835087415},{"date":"2022-01-07","current":13.445749,"twenty":-3.140452,"median":-2.236529,"eighty":12.5827,"marketCap":9761613436},{"date":"2022-01-14","current":13.931922,"twenty":-3.140452,"median":-2.236529,"eighty":12.5827,"marketCap":10114575730},{"date":"2022-01-21","current":12.929189,"twenty":-3.140452,"median":-2.236529,"eighty":12.5827,"marketCap":9386590999},{"date":"2022-01-28","current":12.670909,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":9199079781},{"date":"2022-02-04","current":12.929189,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":9386590999},{"date":"2022-02-11","current":22.56931,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":9411402306},{"date":"2022-02-18","current":21.563878,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":8992137022},{"date":"2022-02-25","current":22.119511,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":9223836258},{"date":"2022-03-04","current":19.738224,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":8230839532},{"date":"2022-03-11","current":19.791142,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":8252906126},{"date":"2022-03-18","current":21.008826,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":8760680412},{"date":"2022-03-25","current":22.952608,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":9571237662},{"date":"2022-04-01","current":25.002899,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":10426209007},{"date":"2022-04-08","current":27.692242,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":11547664928},{"date":"2022-04-14","current":27.133072,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":11314490925},{"date":"2022-04-22","current":24.283966,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":10126413860},{"date":"2022-04-29","current":23.192253,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":9671169377},{"date":"2022-05-06","current":-14.154736,"twenty":-3.172242,"median":-2.25283,"eighty":12.488311,"marketCap":8705162792},{"date":"2022-05-13","current":-14.0103,"twenty":-3.205318,"median":-2.260954,"eighty":12.429626,"marketCap":8616334600},{"date":"2022-05-20","current":-15.29217,"twenty":-3.276345,"median":-2.281282,"eighty":12.245781,"marketCap":9404684802},{"date":"2022-05-27","current":-16.321278,"twenty":-3.31569,"median":-2.291347,"eighty":11.985489,"marketCap":10037585668},{"date":"2022-06-03","current":-16.790695,"twenty":-3.328426,"median":-2.29948,"eighty":11.789502,"marketCap":10326277292},{"date":"2022-06-10","current":-15.021353,"twenty":-3.371392,"median":-2.314197,"eighty":11.688865,"marketCap":9238131943},{"date":"2022-06-17","current":-13.920028,"twenty":-3.408869,"median":-2.342978,"eighty":11.639906,"marketCap":8560816980},{"date":"2022-06-24","current":-13.974191,"twenty":-3.452748,"median":-2.356224,"eighty":11.348874,"marketCap":8594127552},{"date":"2022-07-01","current":-14.245009,"twenty":-3.539192,"median":-2.386785,"eighty":10.834809,"marketCap":8760680412},{"date":"2022-07-08","current":-13.432556,"twenty":-3.647481,"median":-2.418306,"eighty":10.77515,"marketCap":8261021833},{"date":"2022-07-15","current":-12.656212,"twenty":-3.692345,"median":-2.440647,"eighty":10.695627,"marketCap":7783570302},{"date":"2022-07-22","current":-12.656212,"twenty":-3.733536,"median":-2.456867,"eighty":10.545138,"marketCap":7783570302},{"date":"2022-07-29","current":-9.883393,"twenty":-3.783945,"median":-2.463627,"eighty":10.456545,"marketCap":10417096473},{"date":"2022-08-05","current":-11.263697,"twenty":-3.859125,"median":-2.480033,"eighty":10.139869,"marketCap":11871936172},{"date":"2022-08-12","current":-11.811603,"twenty":-4.662476,"median":-2.488236,"eighty":9.908676,"marketCap":12449429793},{"date":"2022-08-19","current":-10.926523,"twenty":-4.855781,"median":-2.509199,"eighty":9.496608,"marketCap":11516555482},{"date":"2022-08-26","current":-10.104663,"twenty":-7.328779,"median":-2.526918,"eighty":9.235909,"marketCap":10650315051},{"date":"2022-09-02","current":-9.314413,"twenty":-7.460438,"median":-2.534518,"eighty":8.539587,"marketCap":9817391559},{"date":"2022-09-09","current":-9.662123,"twenty":-7.588383,"median":-2.544228,"eighty":8.396377,"marketCap":10183877895},{"date":"2022-09-16","current":-9.282803,"twenty":-7.708389,"median":-2.560413,"eighty":7.75588,"marketCap":9784074619},{"date":"2022-09-23","current":-8.323967,"twenty":-7.837841,"median":-2.564286,"eighty":7.146957,"marketCap":8773460782},{"date":"2022-09-30","current":-8.50309,"twenty":-7.954693,"median":-2.577477,"eighty":6.631627,"marketCap":8962256773},{"date":"2022-10-07","current":-8.91402,"twenty":-8.041279,"median":-2.589545,"eighty":1.906977,"marketCap":9395376989},{"date":"2022-10-14","current":-8.37665,"twenty":-8.108759,"median":-2.602979,"eighty":-1.058703,"marketCap":8828989015},{"date":"2022-10-21","current":-8.892947,"twenty":-8.254205,"median":-2.612933,"eighty":-1.077333,"marketCap":9373165696},{"date":"2022-10-28","current":-9.38817,"twenty":-8.370996,"median":-2.61826,"eighty":-1.103341,"marketCap":9895131084},{"date":"2022-11-04","current":-7.286725,"twenty":-8.4182,"median":-2.627686,"eighty":-1.11572,"marketCap":9407161532},{"date":"2022-11-11","current":-8.155626,"twenty":-8.4182,"median":-2.640011,"eighty":-1.122973,"marketCap":10528912789},{"date":"2022-11-18","current":-7.501799,"twenty":-8.4182,"median":-2.646916,"eighty":-1.133601,"marketCap":9684822734},{"date":"2022-11-25","current":-7.630844,"twenty":-8.4182,"median":-2.652295,"eighty":-1.154623,"marketCap":9851419455},{"date":"2022-12-02","current":-7.450181,"twenty":-8.4182,"median":-2.657764,"eighty":-1.167975,"marketCap":9618184045},{"date":"2022-12-09","current":-7.260916,"twenty":-8.4182,"median":-2.667232,"eighty":-1.196871,"marketCap":9373842187},{"date":"2022-12-16","current":-7.47599,"twenty":-8.4182,"median":-2.670589,"eighty":-1.206624,"marketCap":9651503390},{"date":"2022-12-23","current":-7.949154,"twenty":-8.4182,"median":-2.679639,"eighty":-1.218984,"marketCap":10262358035},{"date":"2022-12-30","current":-7.845918,"twenty":-8.4182,"median":-2.685107,"eighty":-1.245981,"marketCap":10129080658},{"date":"2023-01-06","current":-9.050336,"twenty":-8.490335,"median":-2.685107,"eighty":-1.245981,"marketCap":11683983390},{"date":"2023-01-13","current":-9.66975,"twenty":-8.513614,"median":-2.685107,"eighty":-1.245981,"marketCap":12483647653},{"date":"2023-01-20","current":-8.955703,"twenty":-8.55512,"median":-2.685107,"eighty":-1.245981,"marketCap":11561812461},{"date":"2023-01-27","current":-8.929894,"twenty":-8.616931,"median":-2.685107,"eighty":-1.245981,"marketCap":11528493117},{"date":"2023-02-03","current":-9.256807,"twenty":-8.658116,"median":-2.685107,"eighty":-1.245981,"marketCap":11950538144},{"date":"2023-02-10","current":-4.843957,"twenty":-8.665667,"median":-2.696044,"eighty":-1.249887,"marketCap":11397831773},{"date":"2023-02-17","current":-4.749533,"twenty":-8.665667,"median":-2.710028,"eighty":-1.287834,"marketCap":11175651816},{"date":"2023-02-24","current":-4.678715,"twenty":-8.665667,"median":-2.721577,"eighty":-1.357669,"marketCap":11009016849},{"date":"2023-03-03","current":-4.740091,"twenty":-8.665667,"median":-2.726931,"eighty":-1.387204,"marketCap":11153433821},{"date":"2023-03-10","current":-4.30574,"twenty":-8.665667,"median":-2.735171,"eighty":-1.40268,"marketCap":10131406020},{"date":"2023-03-17","current":-3.946928,"twenty":-8.665667,"median":-2.743833,"eighty":-1.47613,"marketCap":9287122185},{"date":"2023-03-24","current":-3.984698,"twenty":-8.665667,"median":-2.762598,"eighty":-1.494118,"marketCap":9375994168},{"date":"2023-03-31","current":-4.178267,"twenty":-8.663663,"median":-2.769529,"eighty":-1.502762,"marketCap":9831463079},{"date":"2023-04-06","current":-4.34351,"twenty":-8.663663,"median":-2.77623,"eighty":-1.523472,"marketCap":10220278003},{"date":"2023-04-14","current":-4.371837,"twenty":-8.665667,"median":-2.787387,"eighty":-1.5314,"marketCap":10286931990},{"date":"2023-04-21","current":-3.975941,"twenty":-8.665667,"median":-2.794986,"eighty":-1.543656,"marketCap":9355388563},{"date":"2023-04-28","current":-4.056888,"twenty":-8.665667,"median":-2.80155,"eighty":-1.553815,"marketCap":9545857552},{"date":"2023-05-05","current":-4.128312,"twenty":-8.665667,"median":-2.808152,"eighty":-1.565328,"marketCap":9713918424},{"date":"2023-05-12","current":-5.734745,"twenty":-8.66767,"median":-2.811371,"eighty":-1.580115,"marketCap":9198531749},{"date":"2023-05-19","current":-5.769671,"twenty":-8.66767,"median":-2.815669,"eighty":-1.600505,"marketCap":9254552040},{"date":"2023-05-26","current":-5.123253,"twenty":-8.66767,"median":-2.823193,"eighty":-1.733806,"marketCap":8212574631},{"date":"2023-06-02","current":-5.03239,"twenty":-8.66767,"median":-2.827292,"eighty":-1.759051,"marketCap":8066921875},{"date":"2023-06-09","current":-5.16519,"twenty":-8.66767,"median":-2.83303,"eighty":-1.79258,"marketCap":8279798980},{"date":"2023-06-16","current":-5.297989,"twenty":-8.66767,"median":-2.842331,"eighty":-1.834111,"marketCap":8492676085},{"date":"2023-06-23","current":-5.277021,"twenty":-8.669674,"median":-2.850882,"eighty":-1.8531,"marketCap":8459063910},{"date":"2023-06-30","current":-5.290999,"twenty":-8.685793,"median":-2.853491,"eighty":-1.884437,"marketCap":8481472027},{"date":"2023-07-07","current":-5.472725,"twenty":-8.699909,"median":-2.856943,"eighty":-1.893935,"marketCap":8772777539},{"date":"2023-07-14","current":-5.661439,"twenty":-8.714024,"median":-2.86215,"eighty":-1.904829,"marketCap":9075287109},{"date":"2023-07-21","current":-5.920048,"twenty":-8.714024,"median":-2.865002,"eighty":-1.93738,"marketCap":9489837261},{"date":"2023-07-28","current":-5.885101,"twenty":-8.714024,"median":-2.873833,"eighty":-1.952158,"marketCap":9433816970},{"date":"2023-08-04","current":-4.800636,"twenty":-8.72814,"median":-2.888799,"eighty":-1.955074,"marketCap":10724621897},{"date":"2023-08-11","current":-4.840767,"twenty":-8.72814,"median":-2.904838,"eighty":-1.955074,"marketCap":10814273908},{"date":"2023-08-18","current":-4.770538,"twenty":-8.72814,"median":-2.911332,"eighty":-1.955074,"marketCap":10657382888},{"date":"2023-08-25","current":-4.8508,"twenty":-8.72814,"median":-2.931253,"eighty":-1.955074,"marketCap":10836686911},{"date":"2023-09-01","current":-4.895947,"twenty":-8.72814,"median":-2.939134,"eighty":-1.955074,"marketCap":10937545424},{"date":"2023-09-08","current":-4.690277,"twenty":-8.72814,"median":-2.954829,"eighty":-1.955074,"marketCap":10478078865},{"date":"2023-09-14","current":-5.181878,"twenty":-8.72814,"median":-2.957009,"eighty":-1.955074,"marketCap":11576316008},{"date":"2023-09-22","current":-5.186895,"twenty":-8.742256,"median":-2.966419,"eighty":-1.954647,"marketCap":11587522509},{"date":"2023-09-29","current":-5.126699,"twenty":-8.742256,"median":-2.976841,"eighty":-1.954512,"marketCap":11453044492},{"date":"2023-10-06","current":-4.685261,"twenty":-8.742256,"median":-2.992075,"eighty":-1.954512,"marketCap":10466872363},{"date":"2023-10-13","current":-4.479591,"twenty":-8.742256,"median":-3.004047,"eighty":-1.954512,"marketCap":10007405803},{"date":"2023-10-20","current":-4.093333,"twenty":-8.742256,"median":-3.015213,"eighty":-1.954377,"marketCap":9144505191},{"date":"2023-10-27","current":-4.148512,"twenty":-8.742256,"median":-3.027087,"eighty":-1.953971,"marketCap":9267776707},{"date":"2023-11-03","current":-4.404346,"twenty":-8.742256,"median":-3.039408,"eighty":-1.953971,"marketCap":9839308281},{"date":"2023-11-10","current":-4.449118,"twenty":-8.742256,"median":-3.054185,"eighty":-1.953971,"marketCap":9828101780},{"date":"2023-11-17","current":-4.445318,"twenty":-8.742256,"median":-3.083177,"eighty":-1.953971,"marketCap":9819707729},{"date":"2023-11-24","current":-4.846209,"twenty":-8.742256,"median":-3.094417,"eighty":-1.953971,"marketCap":10705274979},{"date":"2023-12-01","current":-4.983222,"twenty":-8.742256,"median":-3.11228,"eighty":-1.953971,"marketCap":11007937203},{"date":"2023-12-08","current":-5.05934,"twenty":-8.742256,"median":-3.121898,"eighty":-1.957883,"marketCap":11176082883},{"date":"2023-12-15","current":-5.191279,"twenty":-8.742256,"median":-3.140281,"eighty":-1.964182,"marketCap":11467535396},{"date":"2023-12-22","current":-5.373963,"twenty":-8.742256,"median":-3.175748,"eighty":-1.973937,"marketCap":11871085029},{"date":"2023-12-29","current":-5.313069,"twenty":-8.742256,"median":-3.194657,"eighty":-1.979923,"marketCap":11736568484},{"date":"2024-01-05","current":-5.521126,"twenty":-8.744895,"median":-3.254473,"eighty":-1.994731,"marketCap":12196166677},{"date":"2024-01-12","current":-5.785003,"twenty":-8.747534,"median":-3.303065,"eighty":-2.020282,"marketCap":12779071702},{"date":"2024-01-19","current":-5.576946,"twenty":-8.750172,"median":-3.324939,"eighty":-2.086994,"marketCap":12319473509},{"date":"2024-01-26","current":-6.003209,"twenty":-8.747534,"median":-3.350993,"eighty":-2.113662,"marketCap":13261089319},{"date":"2024-02-02","current":-24.986228,"twenty":-8.792334,"median":-3.394528,"eighty":-2.231182,"marketCap":13967301176},{"date":"2024-02-09","current":-24.244261,"twenty":-8.880303,"median":-3.546059,"eighty":-2.28208,"marketCap":13552541832},{"date":"2024-02-16","current":-26.473061,"twenty":-8.902871,"median":-3.699813,"eighty":-2.289098,"marketCap":14798440945},{"date":"2024-02-23","current":-26.169858,"twenty":-8.923739,"median":-3.699813,"eighty":-2.289098,"marketCap":14628950780},{"date":"2024-03-01","current":-26.370394,"twenty":-9.053777,"median":-3.70305,"eighty":-2.290222,"marketCap":14741050020},{"date":"2024-03-08","current":-27.493391,"twenty":-9.139505,"median":-3.70305,"eighty":-2.290222,"marketCap":15368805762},{"date":"2024-03-15","current":-27.072267,"twenty":-9.210651,"median":-3.70305,"eighty":-2.290222,"marketCap":15133397359},{"date":"2024-03-22","current":-27.573605,"twenty":-9.283565,"median":-3.70305,"eighty":-2.290222,"marketCap":15413645458},{"date":"2024-03-28","current":-28.937246,"twenty":-9.314413,"median":-3.70305,"eighty":-2.290222,"marketCap":16175920288},{"date":"2024-04-05","current":-27.934569,"twenty":-9.368646,"median":-3.699813,"eighty":-2.289098,"marketCap":15615424090},{"date":"2024-04-12","current":-27.814248,"twenty":-9.433738,"median":-3.699813,"eighty":-2.289098,"marketCap":15548164546},{"date":"2024-04-19","current":-25.894717,"twenty":-9.525147,"median":-3.699813,"eighty":-2.289098,"marketCap":14475146829},{"date":"2024-04-26","current":-26.847027,"twenty":-9.663648,"median":-3.70305,"eighty":-2.290222,"marketCap":15007487910},{"date":"2024-05-03","current":-28.528765,"twenty":-9.858133,"median":-3.70305,"eighty":-2.290222,"marketCap":15947579605},{"date":"2024-05-10","current":-37.912656,"twenty":-10.011941,"median":-3.70305,"eighty":-2.290222,"marketCap":18122249552},{"date":"2024-05-17","current":-38.623518,"twenty":-10.428566,"median":-3.735419,"eighty":-2.290222,"marketCap":18462041731},{"date":"2024-05-24","current":-39.713507,"twenty":-10.612531,"median":-3.918801,"eighty":-2.290222,"marketCap":18983056405},{"date":"2024-05-31","current":-40.043539,"twenty":-10.762386,"median":-3.985619,"eighty":-2.290222,"marketCap":19140811509},{"date":"2024-06-07","current":-39.356401,"twenty":-11.036489,"median":-4.027189,"eighty":-2.290222,"marketCap":18812359714},{"date":"2024-06-14","current":-41.228259,"twenty":-11.179023,"median":-4.073267,"eighty":-2.289098,"marketCap":19707107707},{"date":"2024-06-21","current":-40.422649,"twenty":-11.296334,"median":-4.121613,"eighty":-2.287973,"marketCap":19322026292},{"date":"2024-06-28","current":-38.527097,"twenty":-11.385149,"median":-4.151587,"eighty":-2.285634,"marketCap":18415952375},{"date":"2024-07-05","current":-39.853984,"twenty":-11.621943,"median":-4.174737,"eighty":-2.285634,"marketCap":19050204117},{"date":"2024-07-12","current":-40.517427,"twenty":-11.801067,"median":-4.198404,"eighty":-2.285634,"marketCap":19367329988},{"date":"2024-07-15","current":-40.943926,"twenty":-11.803174,"median":-4.207927,"eighty":-2.285634,"marketCap":19571196620},{"date":"2024-08-02","current":-43.865831,"twenty":-12.11229,"median":-4.314015,"eighty":-2.263795,"marketCap":19871221474},{"date":"2024-08-09","current":-42.918652,"twenty":-12.52622,"median":-4.371837,"eighty":-2.286849,"marketCap":19442149532},{"date":"2024-08-16","current":-45.844924,"twenty":-12.72843,"median":-4.404346,"eighty":-2.300344,"marketCap":20767750637},{"date":"2024-08-23","current":-45.994989,"twenty":-13.2484,"median":-4.445318,"eighty":-2.342265,"marketCap":20835730180},{"date":"2024-08-30","current":-46.845359,"twenty":-13.425334,"median":-4.479591,"eighty":-2.416103,"marketCap":21220947595},{"date":"2024-09-06","current":-46.095033,"twenty":-13.573381,"median":-4.534771,"eighty":-2.445786,"marketCap":20881049876},{"date":"2024-09-13","current":-45.044576,"twenty":-13.790035,"median":-4.59248,"eighty":-2.462375,"marketCap":20405193069},{"date":"2024-09-20","current":-44.419305,"twenty":-13.920028,"median":-4.678715,"eighty":-2.479685,"marketCap":20121944970},{"date":"2024-09-27","current":-44.369283,"twenty":-14.16918,"median":-4.685261,"eighty":-2.507741,"marketCap":20099285122},{"date":"2024-10-04","current":-43.468892,"twenty":-14.281118,"median":-4.725391,"eighty":-2.528045,"marketCap":19691407859},{"date":"2024-10-11","current":-43.543924,"twenty":-14.56378,"median":-4.755489,"eighty":-2.551354,"marketCap":19725397631},{"date":"2024-10-18","current":-44.919522,"twenty":-14.798864,"median":-4.790604,"eighty":-2.565388,"marketCap":20348543450},{"date":"2024-10-25","current":-45.644837,"twenty":-14.9835,"median":-4.800636,"eighty":-2.581284,"marketCap":20677111245},{"date":"2024-10-31","current":-46.495207,"twenty":-15.044047,"median":-4.830735,"eighty":-2.591832,"marketCap":21062328660},{"date":"2024-11-08","current":-20.676099,"twenty":-15.165789,"median":-4.848504,"eighty":-2.610103,"marketCap":19828378745},{"date":"2024-11-15","current":-19.78998,"twenty":-15.257672,"median":-4.864345,"eighty":-2.614015,"marketCap":18978591084},{"date":"2024-11-22","current":-20.179872,"twenty":-15.324068,"median":-4.893439,"eighty":-2.614015,"marketCap":19352497655},{"date":"2024-11-29","current":-19.852409,"twenty":-15.363905,"median":-4.906541,"eighty":-2.614015,"marketCap":19038460421},{"date":"2024-12-06","current":-21.082833,"twenty":-15.616208,"median":-4.978148,"eighty":-2.614015,"marketCap":20218436514},{"date":"2024-12-13","current":-19.887902,"twenty":-15.887969,"median":-5.021355,"eighty":-2.615541,"marketCap":19072498193},{"date":"2024-12-20","current":-25.21185,"twenty":-16.001301,"median":-5.037892,"eighty":-2.615541,"marketCap":24178163980},{"date":"2024-12-27","current":-26.76171,"twenty":-16.173929,"median":-5.056349,"eighty":-2.615541,"marketCap":25664480020},{"date":"2025-01-03","current":-25.200019,"twenty":-16.249059,"median":-5.107143,"eighty":-2.617065,"marketCap":24166818056},{"date":"2025-01-10","current":-25.424808,"twenty":-16.357877,"median":-5.126699,"eighty":-2.628591,"marketCap":24382390611},{"date":"2025-01-17","current":-25.649597,"twenty":-16.471424,"median":-5.161813,"eighty":-2.638802,"marketCap":24597963166},{"date":"2025-01-24","current":-25.779738,"twenty":-16.785953,"median":-5.191279,"eighty":-2.638802,"marketCap":24722768330},{"date":"2025-01-31","current":-12.349682,"twenty":-16.846119,"median":-5.228095,"eighty":-2.638802,"marketCap":20241128362},{"date":"2025-02-07","current":-11.960995,"twenty":-16.846119,"median":-5.277021,"eighty":-2.638802,"marketCap":19604070932},{"date":"2025-02-14","current":-11.504416,"twenty":-16.846119,"median":-5.287221,"eighty":-2.638802,"marketCap":18855737398},{"date":"2025-02-21","current":-11.884843,"twenty":-16.846119,"median":-5.287221,"eighty":-2.638802,"marketCap":19479257713},{"date":"2025-02-28","current":-11.409449,"twenty":-16.846119,"median":-5.287221,"eighty":-2.638802,"marketCap":18700087404},{"date":"2025-03-07","current":-10.731314,"twenty":-16.84738,"median":-5.284921,"eighty":-2.637593,"marketCap":17588623876},{"date":"2025-03-14","current":-11.507324,"twenty":-16.84738,"median":-5.284921,"eighty":-2.637593,"marketCap":18860504820},{"date":"2025-03-21","current":-11.353521,"twenty":-16.84738,"median":-5.284921,"eighty":-2.637593,"marketCap":18608420309},{"date":"2025-03-28","current":-10.829189,"twenty":-16.84738,"median":-5.284921,"eighty":-2.637593,"marketCap":17749041292},{"date":"2025-04-04","current":-10.38176,"twenty":-16.84738,"median":-5.284921,"eighty":-2.637593,"marketCap":17015704531},{"date":"2025-04-11","current":-8.96257,"twenty":-16.846119,"median":-5.287221,"eighty":-2.638802,"marketCap":14689651992},{"date":"2025-04-17","current":-9.389026,"twenty":-16.846119,"median":-5.287221,"eighty":-2.638802,"marketCap":15388613593},{"date":"2025-04-25","current":-10.300945,"twenty":-16.84738,"median":-5.284921,"eighty":-2.637593,"marketCap":16883249065},{"date":"2025-05-02","current":-10.930758,"twenty":-16.84738,"median":-5.284921,"eighty":-2.637593,"marketCap":17915512935},{"date":"2025-05-09","current":-16.116302,"twenty":-16.84738,"median":-5.284921,"eighty":-2.637593,"marketCap":20725564579}],"updateTime":1746979582023}}}